Oral resveratrol reduces neuronal damage in a model of multiple sclerosis. - Wikidata - wikimedia - TriplyDB

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.

http://www.wikidata.org/entity/Q35854099

about

Protective effects and mechanisms of sirtuins in the nervous system Non-coding RNA in neural function, disease, and aging Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis Sirtuin deacylases: a molecular link between metabolism and immunity Rapid and simultaneous in situ assessment of aflatoxins and stilbenes using silica plate imprinting mass spectrometry imaging Mitochondrial Uncoupler Prodrug of 2,4-Dinitrophenol, MP201, Prevents Neuronal Damage and Preserves Vision in Experimental Optic Neuritis A novel microRNA-132-sirtuin-1 axis underlies aberrant B-cell cytokine regulation in patients with relapsing-remitting multiple sclerosis [corrected].Vision in multiple sclerosis: the story, structure-function correlations, and models for neuroprotection.HE3286 reduces axonal loss and preserves retinal ganglion cell function in experimental optic neuritis.SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function Pharmacologic Means of Extending Lifespan.Axonal degeneration in multiple sclerosis: can we predict and prevent permanent disability?The influence of nutritional factors on the prognosis of multiple sclerosis.Sirtuin1 over-expression does not impact retinal vascular and neuronal degeneration in a mouse model of oxygen-induced retinopathy.Promise of resveratrol for easing status epilepticus and epilepsy.Resveratrol neuroprotection in a chronic mouse model of multiple sclerosis.Excitotoxins, Mitochondrial and Redox Disturbances in Multiple Sclerosis.Sirtuin regulation in aging and injury Are sirtuins viable targets for improving healthspan and lifespan?SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells.Interplay between exercise and dietary fat modulates myelinogenesis in the central nervous system.Ganglion cell loss in relation to visual disability in multiple sclerosis.SIRT1 promotes RGC survival and delays loss of function following optic nerve crush.Effects of Resveratrol and trans-3,5,4'-Trimethoxystilbene on Glutamate-Induced Cytotoxicity, Heme Oxygenase-1, and Sirtuin 1 in HT22 Neuronal Cells SIRT1 activating compounds reduce oxidative stress mediated neuronal loss in viral induced CNS demyelinating disease Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model.Overexpression of SIRT1 protein in neurons protects against experimental autoimmune encephalomyelitis through activation of multiple SIRT1 targets Small molecule SIRT1 activators for the treatment of aging and age-related diseases.Mitochondrial sirtuins--a new therapeutic target for repair and protection in multiple sclerosis.Matters of life and death: the role of chromatin remodeling proteins in retinal neuron survival Molecular mechanisms of retinal ganglion cell degeneration in glaucoma and future prospects for cell body and axonal protection.Polyphenols: multipotent therapeutic agents in neurodegenerative diseases.Sirtuins: from metabolic regulation to brain aging.Neuroprotection in multiple sclerosis: a therapeutic approach.SIRT1 in neurodevelopment and brain senescence.Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.Mitochondrial dysfunction in central nervous system white matter disorders.Role of SIRT1 in autoimmune demyelination and neurodegeneration.Nutritional supplements in age-related macular degeneration.Resveratrol supplementation: Where are we now and where should we go?

P2860

Q26825585-705FF1C4-077C-4821-967E-B07CE25E4604 Q28080682-0C5E5FB8-FFB9-4E33-964E-3914AEDC09F4 Q28080754-F530EF64-01EB-4B5A-A1A0-B799483B5B66 Q28283588-252C5181-B8AC-47D5-BA8F-67CAB8015B24 Q28540399-DA68C7F3-BF62-40FA-B78B-59AE9C34C2A3 Q33820029-661C7C43-6133-438C-93DF-F1BE4DCB0795 Q34066554-9CFAA78B-2AF2-44E2-8448-E3483D42CD74 Q34076168-2C45EB69-C3B4-4275-A11F-4D46C0EA7244 Q34166691-946F8126-2A46-44EC-A1F3-49619763D7B1 Q34272924-227D28A6-0754-49CA-8433-355ED366237B Q34449372-CBC3DAFF-8DA0-46F8-A44D-1FE9D9F40934 Q34570124-DA4864E8-A09F-41E4-99D1-798FF0CCF7E0 Q34643392-2AEC0969-4E27-47D2-BD32-F8F545FA999C Q35085010-54C693D9-A449-4082-AB77-62D6941461E1 Q35097960-378C9C44-49FA-4B5F-8B8E-A591288B67DF Q35985952-F6B8ECE4-E300-46E6-AFFC-A717977165D5 Q36283207-546B9ECA-3AD0-4105-8551-14A389C6ECE4 Q36379286-7BDD6F06-816B-476E-91D4-14C7212B6C07 Q36385747-1E400407-DBB6-4F85-BB25-29AC92CBC0C9 Q36496948-EDE8EB07-2664-484D-A353-2D1FAB1BB448 Q36678075-DC96F4CB-3524-4DEF-9F0A-7D6F5FEB6CED Q36781704-9F3C992D-B5D9-4D51-A483-AC0E7A1A54B5 Q37053162-3A434358-9976-4A3C-8815-C24E434F50F8 Q37224583-692BFB45-BD85-4661-B304-B9B8901E66EB Q37480249-28C0B8B0-4994-4730-B08E-9F27B8E41FE7 Q37615358-E85E801E-7889-41F5-B38C-E49EA54C0E71 Q37657902-3F2EE9F0-52D2-455E-B084-ECB071DB3D8A Q37673310-A7BBEAE0-6593-42EC-A14F-E34DFCF06AA0 Q38019568-568CB2E8-5D7C-425B-B742-89B7E43DAA76 Q38071621-6D2D127F-4CCA-420F-95EF-98C7737D9A74 Q38073754-B5DD28D0-C7E3-448E-909F-32045C31C885 Q38120532-661A0D79-F6C8-4F12-BEDD-FD45796FFBD2 Q38124259-B646751A-2E96-490C-93FA-DC573D165CBF Q38129748-ED877AEF-0A62-4F61-AE9B-1F65E279C6E7 Q38186171-22C92738-9608-4675-A578-B74033E5EB41 Q38196701-F2B4CBFD-4C4C-4A42-844A-FC2270CA375C Q38215315-664A5EEB-1439-4934-927F-63FE67704AD7 Q38256576-BA9F5E8A-7E7F-4321-8AB3-3286CAAF9FF1 Q38317289-707EC1B1-7ED5-408D-B493-1DDDACE2EACB Q38334249-48C4EFE8-381A-40AD-AD62-3028843FAD1E

P2860

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.

http://www.wikidata.org/entity/Q35854099

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.

@ast

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.

@en

type

label

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.

@ast

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.

@en

prefLabel

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.

@ast

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.

@en

P1433

Q35854099-8244E2C9-4B23-41CB-93C4-ECAF4C128D11

P1476

Q35854099-0172F525-EF63-4E18-B508-9AE15256D06E

P2093

Q35854099-0C3C7366-8CDD-41E9-97FB-8E954626879E

Q35854099-1494725E-B09E-4743-B823-78C495F4706C

Q35854099-350EA3FE-C36D-4E1E-AC00-97C6C274405A

Q35854099-C29471BB-B26D-4EB1-9FBF-1C6423C52541

Q35854099-D3146849-1B27-4658-9C7D-A74F5FBA4C00

Q35854099-F0C8D92A-C4A4-422B-A92C-7E2F8484EA27

P2860

Q35854099-05731CD4-E4F7-45DA-B20A-8B31936D742F

Q35854099-0741ADC5-D071-44A8-BF85-6F4F21547AD6

Q35854099-19B29912-957F-4C7C-A80D-5198AEF1CBAC

Q35854099-1A9225B7-08B2-414D-94C9-14FA8BD905BA

Q35854099-1CF4383C-83A2-48B0-8CE8-D3505F749FE6

Q35854099-34796F5C-9254-4440-AFD7-C62D74AD261A

Q35854099-3D7358C1-8282-44CD-A2AC-B99CDEB0E249

Q35854099-65471C25-EACA-44A5-A3C0-8C4690174919

Q35854099-7659AB0E-0421-4F16-BEFF-BC46ECE920E8

Q35854099-7A6A92E4-3CDC-4E78-95A9-7592527C06E8

P304

Q35854099-23BAEAF0-252A-4154-B426-64ABBBD35CF3

P31

Q35854099-DCA800BD-1D75-468B-BA71-C8A4468CA5DE

P356

Q35854099-C3C1A667-F703-48C4-B138-D12CE26869B5

P433

Q35854099-A9A25AE2-75D5-4023-815B-F5BF92487239

P478

Q35854099-2D7140E9-0A6C-472D-ABAA-ADFADB1CE5E3

P577

Q35854099-41528E53-7EF0-4CDE-9494-50E920C66C52

P698

Q35854099-F99AE01E-4548-413A-B258-CE2A22FF56DF

P921

Q35854099-0CAA57FD-E710-43CF-9F82-4DC27CD32B37

P932

Q35854099-C582FE05-92DD-43FA-9188-603736DB26C0

P356

WNO.0B013E3181F7F833

P1433

Journal of Neuro-Ophthalmology

P1476

Oral resveratrol reduces neuronal damage in a model of multiple sclerosis.

@en

P2093

Abdolmohamad Rostami

http://www.w3.org/2001/XMLSchema#string

Denise C Fitzgerald

http://www.w3.org/2001/XMLSchema#string

Elvira Ventura

http://www.w3.org/2001/XMLSchema#string

Kenneth S Shindler

http://www.w3.org/2001/XMLSchema#string

Mahasweta Dutt

http://www.w3.org/2001/XMLSchema#string

Peter Elliott

http://www.w3.org/2001/XMLSchema#string

P2860

Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes

Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase

A phylogenetically conserved NAD+-dependent protein deacetylase activity in the Sir2 protein family.

The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases.

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

Metabolic control of muscle mitochondrial function and fatty acid oxidation through SIRT1/PGC-1alpha

Multiple sclerosis

Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

Immunomodulatory effect of combination therapy with lovastatin and 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside alleviates neurodegeneration in experimental autoimmune encephalomyelitis

P304

328-339

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/WNO.0B013E3181F7F833

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21107122

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

3312784

http://www.w3.org/2001/XMLSchema#string